NCT00570193
- Conditions
- Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +8 more
- Locations
-
Not specified
Clinical trial condition
Metaplasia
Explore clinical trials studying Metaplasia. Study availability and eligibility vary by location and protocol.
257 public trials
19 recruiting studies
Metaplasia trial results
NCT01628354
- Conditions
- Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +8 more
- Locations
-
- Royal Victorian Eye and Ear Hospital Melbourne, Victoria, Australia
NCT01256632
- Conditions
- Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +5 more
- Locations
-
- Vision Research Foundation Royal Oak, Michigan, United States
NCT00510965
- Conditions
- Angioid Streaks, Cardiovascular Diseases, Choroid Diseases, +22 more
- Locations
-
- University of Bonn Bonn, Germany
Completed
An OCT-Guided Variable Dosing Regimen With Ranibizumab for the Treatment of Neovascular AMD
NCT00373659
- Conditions
- Eye Diseases, Macular Degeneration, Metaplasia, +6 more
- Locations
-
- Bascom Palmer Eye Instiyute Miami, Florida, United States
NCT01255462
- Conditions
- Advanced Age-related Macular Degeneration, Choroid Diseases, Choroidal Neovascularization, +10 more
- Locations
-
- Retinal Consultants of Arizona, Phoenix, Arizona, United States
- Retina-Vitreous Associates Medical Group, Beverly Hills, California, United States
- National Ophthalmic Research Institute Fort Myers, Florida, United States
- Center for Retina and Macular Disease Winter Haven, Florida, United States
NCT01136252
- Conditions
- Age-Related Macular Degeneration, Choroid Diseases, Choroidal Neovascularization, +9 more
- Locations
-
- Servicio de Oftalmologia. Hospital Universitario Vall d'Hebron Barcelona, Spain
NCT00463320
- Conditions
- Age-Related Macular Degeneration, Choroid Diseases, Choroidal Neovascularization, +9 more
- Locations
-
- GSK Investigational Site Fargo, North Dakota, United States
- GSK Investigational Site Austin, Texas, United States
NCT00797303
- Conditions
- Corneal Diseases, Corneal Neovascularization, Eye Diseases, +4 more
- Locations
-
Not specified
NCT01023295
- Conditions
- Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +6 more
- Locations
-
- OXiGENE Investigational Site Los Angeles, California, United States
- OXiGENE Investigational Site Hong Kong
- OXiGENE Investigational Site Singapore
- OXiGENE Investigational Site Seoul, South Korea